A matrix attachment region (MAR)-binding activity due to a p114 kilodalton protein is found only in human breast carcinomas and not in normal and benign breast disease tissues

Cancer Research

Volumn 56, Issue 3, 1996, Pages 457-462

  Yanagisawa, Junn ^a   Ando, Jiro ^b   Nakayama, Jun ^a   Kohwi, Yoshinori ^a   Kohwi Shigematsu, Terumi ^a  

^a BURNHAM INSTITUTE   (United States)

^b TOCHIGI CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; TUMOR ANTIGEN;

ARTICLE; BREAST CARCINOMA; BREAST DISEASE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; DISSOCIATION CONSTANT; DNA BINDING; DNA DENATURATION; DNA PROBE; EPITHELIUM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SOUTHERN BLOTTING; TUMOR DIFFERENTIATION;

BASE SEQUENCE; BINDING SITES; BREAST; BREAST DISEASES; BREAST NEOPLASMS; DNA; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; MATRIX ATTACHMENT REGION BINDING PROTEINS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0030023847     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Devilee, P , and Cornelisse, C. J. Genetics of human breast cancer Cancer Surv., 9. 605-630, 1990.
2. Ravdin, P M , and Chamness, G C The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers - a review. Gene (Armst), 159. 19-27, 1995
3. Callahan, R. p53 mutations. another breast cancer prognostic factor J Natl Cancer Inst., 84: 826-827, 1992
4. Davidoff, A. M., Humphrey, P. A , Iglehart, J D , and Marks, J R Genetic basis for p53 overexpression in human breast cancer Proc Natl. Acad. Sci USA, 88: 5006-5010, 1991
5. Isola, J , Visakorpi, T., Holli, K., and Kallioniemi, O-P Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients J. Natl Cancer Inst., 84: 1109-1114, 1992.
6. Nelson, W. G , Pienta, K. J., Barrack, E. R., and Coffey, D. S. The role of the nuclear matrix in the organization and function of DNA. Annu. Rev. Biophys. Chem , 15: 457-475, 1986.
7. Cockerill, P N., and Garrard, W T Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell, 44: 273-282, 1986.
8. Gasser, S. M., and Laemmli, U. K. A glimpse at chromosomal order Trends Genet., 3: 16-22, 1987.
9. Forrester, W C., van Genderen, C., Jenuwein, T., and Grosschedl, R. Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions. Science (Washington DC), 265: 1221-1225, 1994.
10. Dickinson, L. A., Joh, T., Kohwi, Y . and Kohwi-Shigematsu, T. A tissue-specific MAR/SAR DNA binding protein with unusual binding site recognition. Cell, 70. 631-645, 1992.
11. Fey, E. G., and Penman, S Nuclear matrix proteins reflect cell type of origin in cultured human cells. Proc. Natl Acad. Sci. USA, 85: 121-125, 1988.
12. Khanuja, P. S., Lehr, J. E., Soule, H D., Gehani, S. K., Noto, A. C., Choudhury, S., Chen, R., and Pienta, K. J. Nuclear matrix proteins in normal and breast cancer cells Cancer Res., 53: 3394-3398, 1993.
13. Millis, R. R., Hanby, A. M., and Girling, A C. The Breast. In: S S Sternberg, D. A. Antonioli, D Carter, S. E. Mills, and H. A. Oberman (eds.), Diagnostic Surgical Pathology, Ed. 2, pp. 323-408. New York: Raven Press, 1994.
14. Dickinson, L A., and Kohwi-Shigematsu, T. Nucleolin is a matrix attachment region DNA-binding protein that specifically recognizes a region with high base-unpairing potential. Mol. Cell Biol., 15: 456-465, 1995.
15. Fackelmayer, F O , Dahm, K , Renz, A., Ramsperger, U., Richter, A. Nucleic acid-binding properties of hnRNP-U/SAF-A, a nuclear-matrix protein which binds DNA and RNA in vivo and in vitro. Eur. J. Biochem., 221: 749-757, 1994.
16. Kohwi-Shigematsu, T. and Kohwi, Y. Torsional stress stabilizes extended base impairing in suppressor sites flanking immunoglobulin heavy chain enhancer. Biochemistry, 29: 9551-9560, 1990.
17. Bode, J., Kohwi, Y., Dickinson, L., Joh, T., Klehr, D., Mielke, C., and Kohwi-Shigematsu, T. Biological significance of unwinding capability of nuclear matrix-associating DNAs. Science. 255: 195-197, 1992.
18. von Kries, J. P , Buck, F., and Stratling, W. H. Chicken MAR binding protein p120 is identical to human heterogeneous nuclear ribonucleoprotein (HnRNP) U. Nucleic Acids Res, 22: 1215-1220, 1994.
19. von Kries, J. P., Buhrmester, H , and Stratling, W H A matrix/scaffold attachment region binding protein: identification, purification, and mode of binding. Cell, 64. 123-135, 1991.
20. Shnitt, S J , and Connolly, J. L. Pathology of benign breast disorders In. J. R. Harris, S. Hellman, I. C. Henderson, and D. W. Kinne (eds.), Breast Diseases, Ed. 2, pp 15-30. Philadelphia: J B. Lippincott Co., 1991.
21. Soule, H. D., Maloney, T. M., Wolman, S. R. Peterson, W. D., Brenz, R., McGrath, C. M., Russe, J., Pauley, R. J., Jones, R. F., and Brooks, S C Isolation and characterization of a spontaneously immortalized human breast epithelial cell lines, MCF-10. Cancer Res , 50: 6075-6086, 1990.
22. Parham, D. M , and Jankowski, J. Transforming growth factor alpha in epithelial proliferative diseases of the breast. J Clin Pathol., 45: 513-516, 1992.
23. Bravo, R., Frank, R., Bundell, P., et al. Cyclin/PCNA is the auxiliary protein of DNA polymerase delta Nature (Lond), 326 515-517, 1987
24. Keyomarsi, K., O'Leary, N., Molnar, G., Lees, E., Fingert, H. J., and Pardee, A. B. Cyclin E. a potential prognostic marker for breast cancer Cancer Res. 54: 380-385, 1994.